CMS must refine data on antipsychotic drug use in nursing homes, OIG says
By
Alicia Lasek
May 07, 2021
The Minimum Data Set should not be CMS’ sole source for determining the number of nursing home residents using antipsychotic drugs, according to a new report from HHS’ Office of the Inspector General.
Avoid antipsychotic use to lessen stroke risk in Alzheimer’s patients: study
By
Alicia Lasek
Oct 29, 2021
The increased odds of experiencing a stroke within 60 days of starting treatment suggests that even short-term antipsychotic use should be avoided if possible, investigators contend.
Pandemic bump in antipsychotics use raises questions about long-term care outcomes
By
Danielle Brown
Apr 12, 2022
The findings raise questions about the short- and long-term effects on the quality of care and health outcomes for residents, the authors say.
Antipsychotic reduction in LTC leads to drug substitutions, more delusions diagnoses
By
Alicia Lasek
Feb 16, 2022
Antipsychotic reduction in long-term care facilities likely results in significant unintended fallout, new data from Canada show. The results mirror those of similar studies in the United States, with...